Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: Outcomes and toxicity

International Journal of Radiation Oncology Biology Physics

Volumn 90, Issue 4, 2014, Pages 918-925

  Pollom, Erqi L ^a   Alagappan, Muthuraman ^a   Von Eyben, Rie ^a   Kunz, Pamela L ^b   Fisher, George A ^b   Ford, James A ^b   Poultsides, George A ^b   Visser, Brendan C ^b   Norton, Jeffrey A ^b   Kamaya, Aya ^b   Cox, Veronica L ^b   Columbo, Laurie A ^a   Koong, Albert C ^a   Chang, Daniel T ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTHERAPY; DIAGNOSIS; PATIENT MONITORING; TOXICITY;

CONFIDENCE INTERVAL; CUMULATIVE INCIDENCE; GASTROINTESTINAL TOXICITIES; INDEPENDENT PREDICTORS; METHODS AND MATERIALS; PANCREATIC ADENOCARCINOMA; PANCREATIC CANCERS; STEREOTACTIC BODY RADIATION THERAPY;

RADIOTHERAPY;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL RATE; TREATMENT OUTCOME; VERY ELDERLY; ADENOCARCINOMA; ANALYSIS OF VARIANCE; CONFIDENCE INTERVAL; GASTROINTESTINAL TRACT; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PANCREATIC NEOPLASMS; PATHOLOGY; RADIATION DOSE; RADIATION RESPONSE; RADIOSURGERY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CONFIDENCE INTERVALS; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL TRACT; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PANCREATIC NEOPLASMS; RADIOSURGERY; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84908193587     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.06.066     Document Type: Article

References (41)

1. C.J. Yeo, J.L. Cameron, and K.D. Lillemoe Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients Ann Surg 221 1995 721 733 discussion 731-733
2. S.F. Sener, A. Fremgen, and H.R. Menck Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database J Am Coll Surg 189 1999 1 7
3. Gastrointestinal Tumor Study Group Treatment of locally unresectable carcinoma of the pancreas: Comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone J Natl Cancer Inst 80 1988 751 755
4. C.G. Moertel, S. Frytak, and R.G. Hahn Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group Cancer 48 1981 1705 1710
5. W. Small Jr., J. Berlin, and G.M. Freedman Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: A multicenter phase II trial J Clin Oncol 26 2008 942 947
6. J.D. Murphy, S. Adusumilli, and K.A. Griffith Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer Int J Radiat Oncol Biol Phys 68 2007 801 808
7. H. Shinchi, S. Takao, and H. Noma Length and quality of survival after external-beam radiotherapy with concurrent continuous 5-fluorouracil infusion for locally unresectable pancreatic cancer Int J Radiat Oncol Biol Phys 53 2002 146 150
8. A.H. Ko, J.M. Quivey, and A.P. Venook A phase II study of fixed-dose rate gemcitabine plus low-dose cisplatin followed by consolidative chemoradiation for locally advanced pancreatic cancer Int J Radiat Oncol Biol Phys 68 2007 809 816
9. M.G. Haddock, R. Swaminathan, and N.R. Foster Gemcitabine, cisplatin, and radiotherapy for patients with locally advanced pancreatic adenocarcinoma: Results of the North Central Cancer Treatment Group Phase II study N9942 J Clin Oncol 25 2007 2567 2572
10. D.T. Chang, A. Swaminath, and M. Kozak Stereotactic body radiotherapy for colorectal liver metastases: A pooled analysis Cancer 117 2011 4060 4069
11. E. Liu, M.H. Stenmark, and M.J. Schipper Stereotactic body radiation therapy for primary and metastatic liver tumors Transl Oncol 6 2013 442 446
12. H. Onishi, K. Kuriyama, and T. Komiyama Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: Patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner Lung Cancer 45 2004 45 55
13. R. Timmerman, R. Paulus, and J. Galvin Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA 303 2010 1070 1076
14. Koong AC, Le QT, Ho A, et al. Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 58:1017-1021.
15. M.S. Didolkar, C.W. Coleman, and M.J. Brenner Image-guided stereotactic radiosurgery for locally advanced pancreatic adenocarcinoma results of first 85 patients J Gastrointest Surg 14 2010 1547 1559
16. A. Mahadevan, S. Jain, and M. Goldstein Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer Int J Radiat Oncol Biol Phys 78 2010 735 742
17. A. Mahadevan, R. Miksad, and M. Goldstein Induction gemcitabine and stereotactic body radiotherapy for locally advanced nonmetastatic pancreas cancer Int J Radiat Oncol Biol Phys 81 2011 e615 e622
18. M.D. Chuong, G.M. Springett, and J.M. Freilich Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated Int J Radiat Oncol Biol Phys 86 2013 516 522
19. J.C. Rwigema, S.D. Parikh, and D.E. Heron Stereotactic body radiotherapy in the treatment of advanced adenocarcinoma of the pancreas Am J Clin Oncol 34 2011 63 69
20. K. Goyal, D. Einstein, and R.A. Ibarra Stereotactic body radiation therapy for nonresectable tumors of the pancreas J Surg Res 174 2012 319 325
21. M. Hoyer, H. Roed, and L. Sengelov Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma Radiother Oncol 76 2005 48 53
22. F. Polistina, G. Costantin, and F. Casamassima Unresectable locally advanced pancreatic cancer: A multimodal treatment using neoadjuvant chemoradiotherapy (gemcitabine plus stereotactic radiosurgery) and subsequent surgical exploration Ann Surg Oncol 17 2010 2092 2101
23. Chang DT, Schellenberg D, Shen J, et al. Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas. Cancer 115:665-672.
24. A.C. Koong, E. Christofferson, and Q.T. Le Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer Int J Radiat Oncol Biol Phys 63 2005 320 323
25. Schellenberg D, Kim J, Christman-Skieller C, et al. Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 81:181-188.
26. D. Schellenberg, K.A. Goodman, and F. Lee Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer Int J Radiat Oncol Biol Phys 72 2008 678 686
27. C. Park, L. Papiez, S. Zhang, M. Story, and R.D. Timmerman Universal survival curve and single fraction equivalent dose: Useful tools in understanding potency of ablative radiotherapy Int J Radiat Oncol Biol Phys 70 2008 847 852
28. Schweikard A, Shiomi H, Adler J. Respiration tracking in radiosurgery. Med Phys 31:2738-2741.
29. A.Y. Minn, A.C. Koong, and D.T. Chang Stereotactic body radiation therapy for gastrointestinal malignancies Front Radiat Ther Oncol 43 2011 412 427
30. P. Therasse, S.G. Arbuck, and E.A. Eisenhauer New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 2000 205 216
31. R.L. Wahl, H. Jacene, and Y. Kasamon From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors J Nucl Med 50 suppl 1 2009 122S 150S
32. J.P. Fine, and R.J. Gray A proportional hazards model for the subdistribution of competing risk J Am Stat Assoc 94 1999 496 509
33. R.J. Gray A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1988 1141 1154
34. R.J. Yaes, P. Patel, and Y. Maruyama On using the linear-quadratic model in daily clinical practice Int J Radiat Oncol Biol Phys 20 1991 1353 1362
35. B.D. Kavanagh, T.E. Schefter, and H.R. Cardenes Interim analysis of a prospective phase I/II trial of SBRT for liver metastases Acta Oncol 45 2006 848 855
36. T.E. Schefter, B.D. Kavanagh, and R.D. Timmerman A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases Int J Radiat Oncol Biol Phys 62 2005 1371 1378
37. J.D. Murphy, C. Christman-Skieller, J. Kim, S. Dieterich, D.T. Chang, and A.C. Koong A dosimetric model of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer Int J Radiat Oncol Biol Phys 78 2010 1420 1426
38. S.H. Bae, M.S. Kim, and C.K. Cho Predictor of severe gastroduodenal toxicity after stereotactic body radiotherapy for abdominopelvic malignancies Int J Radiat Oncol Biol Phys 84 2012 e469 474
39. S.H. Bae, M.S. Kim, and S.Y. Kim Severe intestinal toxicity after stereotactic ablative radiotherapy for abdominopelvic malignancies Int J Colorectal Dis 28 2013 1707 1713
40. M.K. Gurka, S.P. Collins, and R. Slack Stereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: A pilot trial demonstrating safety Radiat Oncol 8 2013 44
41. P. Hammel, F. Huguet, and J.-L. Van Laethem Comparison of chemoradiotherapy (CRT) and chemotherapy (CT) in patients with a locally advanced pancreatic cancer (LAPC) controlled after 4 months of gemcitabine with or without erlotinib: Final results of the international phase III LAP 07 study J Clin Oncol 31(suppl; abstr #LBA4003) 2013